Principal Financial Group Inc. Has $13.69 Million Holdings in Option Care Health, Inc. $OPCH

Principal Financial Group Inc. boosted its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 6.6% in the 1st quarter, Holdings Channel.com reports. The firm owned 508,426 shares of the company’s stock after acquiring an additional 31,574 shares during the period. Principal Financial Group Inc.’s holdings in Option Care Health were worth $13,687,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Royal Bank of Canada boosted its holdings in Option Care Health by 20.7% in the 1st quarter. Royal Bank of Canada now owns 231,161 shares of the company’s stock valued at $8,078,000 after purchasing an additional 39,661 shares during the period. AQR Capital Management LLC increased its holdings in shares of Option Care Health by 162.6% during the first quarter. AQR Capital Management LLC now owns 41,633 shares of the company’s stock worth $1,450,000 after purchasing an additional 25,777 shares during the period. Empowered Funds LLC acquired a new stake in shares of Option Care Health in the first quarter valued at approximately $208,000. Invesco Ltd. raised its position in shares of Option Care Health by 2.7% in the second quarter. Invesco Ltd. now owns 294,363 shares of the company’s stock valued at $9,561,000 after buying an additional 7,678 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Option Care Health by 528.1% in the second quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock valued at $46,000 after buying an additional 1,183 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Stock Down 0.3%

OPCH stock opened at $21.08 on Friday. The stock’s fifty day simple moving average is $21.28 and its two-hundred day simple moving average is $27.16. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85. Option Care Health, Inc. has a 1-year low of $18.01 and a 1-year high of $36.80. The stock has a market cap of $3.31 billion, a P/E ratio of 16.34, a P/E/G ratio of 1.18 and a beta of 0.65.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.03. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The business’s revenue was up 1.3% compared to the same quarter last year. During the same period last year, the firm posted $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Analysts expect that Option Care Health, Inc. will post 1.64 EPS for the current year.

Insider Activity at Option Care Health

In related news, CEO John Charles Rademacher purchased 12,500 shares of Option Care Health stock in a transaction that occurred on Monday, May 4th. The stock was bought at an average price of $21.18 per share, for a total transaction of $264,750.00. Following the completion of the transaction, the chief executive officer owned 695,152 shares in the company, valued at $14,723,319.36. This represents a 1.83% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Timothy P. Sullivan acquired 24,154 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The shares were bought at an average price of $20.69 per share, with a total value of $499,746.26. Following the acquisition, the director directly owned 73,383 shares of the company’s stock, valued at $1,518,294.27. The trade was a 49.06% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last 90 days, insiders purchased 73,264 shares of company stock worth $1,548,316. 1.70% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on OPCH shares. Stephens reissued an “equal weight” rating and set a $24.00 target price (down from $30.00) on shares of Option Care Health in a report on Friday, July 17th. UBS Group reaffirmed a “buy” rating on shares of Option Care Health in a research note on Tuesday, June 16th. Truist Financial set a $30.00 price target on shares of Option Care Health in a report on Friday, May 1st. TD Cowen reduced their price objective on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a research note on Friday, May 1st. Finally, Morgan Stanley set a $28.00 price objective on Option Care Health in a report on Wednesday, May 6th. Eight analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $30.08.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.